Blue Sail Medical Co Ltd
Blue Sail Medical Co.,Ltd. operates as a medical device company in China and internationally. It operates through Health Protection Division; Cardiovascular and Cerebrovascular Department; and Emergency Rescue Division segments. The company offers cardiovascular and cerebrovascular products comprising drug-eluting stents and balloons, conventional balloons, and transcatheter aortic valve replacem… Read more
Blue Sail Medical Co Ltd (002382) - Net Assets
Latest net assets as of September 2025: CN¥9.71 Billion CNY
Based on the latest financial reports, Blue Sail Medical Co Ltd (002382) has net assets worth CN¥9.71 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥16.46 Billion) and total liabilities (CN¥6.75 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥9.71 Billion |
| % of Total Assets | 58.99% |
| Annual Growth Rate | 30.73% |
| 5-Year Change | -0.17% |
| 10-Year Change | 727.92% |
| Growth Volatility | 122.66 |
Blue Sail Medical Co Ltd - Net Assets Trend (2006–2024)
This chart illustrates how Blue Sail Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Blue Sail Medical Co Ltd (2006–2024)
The table below shows the annual net assets of Blue Sail Medical Co Ltd from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥9.80 Billion | +2.64% |
| 2023-12-31 | CN¥9.55 Billion | -9.51% |
| 2022-12-31 | CN¥10.55 Billion | +0.15% |
| 2021-12-31 | CN¥10.54 Billion | +7.32% |
| 2020-12-31 | CN¥9.82 Billion | +16.00% |
| 2019-12-31 | CN¥8.46 Billion | +8.51% |
| 2018-12-31 | CN¥7.80 Billion | +446.09% |
| 2017-12-31 | CN¥1.43 Billion | +9.87% |
| 2016-12-31 | CN¥1.30 Billion | +9.82% |
| 2015-12-31 | CN¥1.18 Billion | +13.20% |
| 2014-12-31 | CN¥1.05 Billion | +6.24% |
| 2013-12-31 | CN¥984.34 Million | +2.34% |
| 2012-12-31 | CN¥961.83 Million | +4.93% |
| 2011-12-31 | CN¥916.68 Million | +1.43% |
| 2010-12-31 | CN¥903.72 Million | +344.61% |
| 2009-12-31 | CN¥203.26 Million | +28.31% |
| 2008-12-31 | CN¥158.41 Million | +63.22% |
| 2007-12-31 | CN¥97.05 Million | +23.15% |
| 2006-12-31 | CN¥78.81 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Blue Sail Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3989.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.67 Billion | 20.44% |
| Common Stock | CN¥1.01 Billion | 12.30% |
| Other Comprehensive Income | CN¥-272.43 Million | -3.33% |
| Other Components | CN¥5.78 Billion | 70.59% |
| Total Equity | CN¥8.19 Billion | 100.00% |
Blue Sail Medical Co Ltd Competitors by Market Cap
The table below lists competitors of Blue Sail Medical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Beijing SinoHytec Co. Ltd. A
SHG:688339
|
$763.11 Million |
|
Tat Techno
NASDAQ:TATT
|
$763.18 Million |
|
Grindwell Norton Limited
NSE:GRINDWELL
|
$763.21 Million |
|
Astronics Corp Cl B
PINK:ATROB
|
$763.27 Million |
|
Employers Holdings Inc
NYSE:EIG
|
$762.61 Million |
|
Sidea Semiconductor Equipment (Shenzhen) Co., Ltd.
SHE:301629
|
$762.30 Million |
|
Zhuzhou Hongda Electronics Corp Ltd Class A
SHE:300726
|
$762.12 Million |
|
Genew Technologies Co Ltd
SHG:688418
|
$761.94 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Blue Sail Medical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 9,548,354,583 to 8,186,411,188, a change of -1,361,943,395 (-14.3%).
- Net loss of 445,608,865 reduced equity.
- Dividend payments of 177,437,082 reduced retained earnings.
- Share repurchases of 30,002,501 reduced equity.
- Other comprehensive income decreased equity by 998,316,886.
- Other factors increased equity by 289,421,939.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-445.61 Million | -5.44% |
| Dividends Paid | CN¥177.44 Million | -2.17% |
| Share Repurchases | CN¥30.00 Million | -0.37% |
| Other Comprehensive Income | CN¥-998.32 Million | -12.19% |
| Other Changes | CN¥289.42 Million | +3.54% |
| Total Change | CN¥- | -14.26% |
Book Value vs Market Value Analysis
This analysis compares Blue Sail Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.99x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 36.76x to 0.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | CN¥0.22 | CN¥7.99 | x |
| 2007-12-31 | CN¥0.27 | CN¥7.99 | x |
| 2008-12-31 | CN¥0.44 | CN¥7.99 | x |
| 2009-12-31 | CN¥0.57 | CN¥7.99 | x |
| 2010-12-31 | CN¥2.02 | CN¥7.99 | x |
| 2011-12-31 | CN¥1.89 | CN¥7.99 | x |
| 2012-12-31 | CN¥1.97 | CN¥7.99 | x |
| 2013-12-31 | CN¥2.10 | CN¥7.99 | x |
| 2014-12-31 | CN¥2.20 | CN¥7.99 | x |
| 2015-12-31 | CN¥2.43 | CN¥7.99 | x |
| 2016-12-31 | CN¥2.65 | CN¥7.99 | x |
| 2017-12-31 | CN¥2.91 | CN¥7.99 | x |
| 2018-12-31 | CN¥10.57 | CN¥7.99 | x |
| 2019-12-31 | CN¥8.75 | CN¥7.99 | x |
| 2020-12-31 | CN¥9.66 | CN¥7.99 | x |
| 2021-12-31 | CN¥10.03 | CN¥7.99 | x |
| 2022-12-31 | CN¥10.48 | CN¥7.99 | x |
| 2023-12-31 | CN¥9.58 | CN¥7.99 | x |
| 2024-12-31 | CN¥8.08 | CN¥7.99 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Blue Sail Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.44%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -7.13%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 2.05x
- Recent ROE (-5.44%) is below the historical average (12.27%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 42.94% | 9.43% | 1.15x | 3.95x | CN¥25.96 Million |
| 2007 | 31.80% | 7.62% | 1.56x | 2.67x | CN¥21.16 Million |
| 2008 | 38.73% | 11.88% | 1.58x | 2.07x | CN¥45.52 Million |
| 2009 | 29.44% | 12.53% | 1.26x | 1.87x | CN¥39.52 Million |
| 2010 | 4.46% | 6.49% | 0.61x | 1.13x | CN¥-50.04 Million |
| 2011 | 3.17% | 3.11% | 0.71x | 1.43x | CN¥-62.61 Million |
| 2012 | 5.32% | 3.84% | 0.81x | 1.71x | CN¥-44.99 Million |
| 2013 | 4.77% | 3.52% | 0.69x | 1.96x | CN¥-51.46 Million |
| 2014 | 5.92% | 4.02% | 0.96x | 1.54x | CN¥-42.56 Million |
| 2015 | 14.39% | 11.28% | 1.01x | 1.27x | CN¥51.95 Million |
| 2016 | 13.94% | 14.05% | 0.81x | 1.22x | CN¥51.18 Million |
| 2017 | 14.08% | 12.75% | 0.86x | 1.29x | CN¥58.25 Million |
| 2018 | 4.45% | 13.07% | 0.21x | 1.63x | CN¥-433.12 Million |
| 2019 | 5.81% | 14.11% | 0.26x | 1.57x | CN¥-352.94 Million |
| 2020 | 17.91% | 22.35% | 0.46x | 1.74x | CN¥776.76 Million |
| 2021 | 10.97% | 14.25% | 0.48x | 1.61x | CN¥102.08 Million |
| 2022 | -3.53% | -7.60% | 0.31x | 1.50x | CN¥-1.43 Billion |
| 2023 | -5.95% | -11.54% | 0.32x | 1.64x | CN¥-1.52 Billion |
| 2024 | -5.44% | -7.13% | 0.37x | 2.05x | CN¥-1.26 Billion |
Industry Comparison
This section compares Blue Sail Medical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,325,445,439
- Average return on equity (ROE) among peers: 12.43%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Blue Sail Medical Co Ltd (002382) | CN¥9.71 Billion | 42.94% | 0.70x | $763.05 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.12 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |